We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence. We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence.
Inhibrx Biosciences Reports Third Quarter 2024 Financial Results PR Newswire SAN DIEGO, Nov. 14, 2024 SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx...
Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation PR Newswire SAN DIEGO, Nov. 4, 2024 SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc...
Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights PR Newswire SAN DIEGO, Aug. 13, 2024 SAN DIEGO, Aug. 13, 2024 /PRNewswire/ -- Inhibrx...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.66 | -4.21455938697 | 15.66 | 16.2 | 14.91 | 60574 | 15.19722551 | CS |
4 | -1.79 | -10.6611078023 | 16.79 | 17.41 | 12.25 | 83233 | 14.88690675 | CS |
12 | -0.5 | -3.22580645161 | 15.5 | 17.79 | 12.25 | 84737 | 15.54903307 | CS |
26 | -3.45 | -18.6991869919 | 18.45 | 18.95 | 10.8 | 125238 | 14.99318866 | CS |
52 | -7.49 | -33.3036905291 | 22.49 | 39.79 | 10.8 | 410323 | 31.66360641 | CS |
156 | -22.12 | -59.5905172414 | 37.12 | 45.989 | 7.67 | 430120 | 25.40910386 | CS |
260 | -4.7 | -23.8578680203 | 19.7 | 50.97 | 7.67 | 346166 | 25.91117629 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約